Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vaginal Progesterone as Prophylactic Against a Second Attack of Antepartum.Haemorrhage in Pregnant Women Diagnosed as Placenta Previa

NCT04725929 is registered in ClinicalTrials.gov with Nourhan Ashraf ElSherbiny as lead sponsor.

NCT NCT04725929
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04725929 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vaginal Progesterone as Prophylactic Against a Second Attack of Antepartum.Haemorrhage in Pregnant Women Diagnosed as Placenta Previa
Lead sponsor
Nourhan Ashraf ElSherbiny
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
July 1, 2021
Enrollment
160 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

placenta previa